WAVE Life Sciences (WVE) Misses Q2 EPS by 4c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.34), $0.04 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $7.65 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform
• UBS Upgrades Mitsubishi Heavy Industries Ltd (7011:JP) (MHVYF) to Buy